| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/30/2009 | US7553484 Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule |
| 06/30/2009 | CA2621950A1 Methods for diagnosing and treating obesity by modulating the activity of auto-antibodies against the melanocortin-4 receptor |
| 06/30/2009 | CA2619381A1 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 06/30/2009 | CA2324970C Improved immunodiagnostic assays using reducing agents |
| 06/30/2009 | CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/30/2009 | CA2259421C Labelling and selection of molecules |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/30/2009 | CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/30/2009 | CA2108119C Glial mitogenic factors, their preparation and use |
| 06/30/2009 | CA2095521C Hepatitis c virus asialoglycoproteins |
| 06/30/2009 | CA2057052C Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 06/25/2009 | WO2009079649A1 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 06/25/2009 | WO2009079634A1 Systems and methods for altering rates of enzymatic processes |
| 06/25/2009 | WO2009079471A1 Method for treating bone fracture with anti-sclerostin antibodies |
| 06/25/2009 | WO2009079335A1 Binding molecules to the human ox40 receptor |
| 06/25/2009 | WO2009079308A2 Composition and method of use of sheep fab phage display library |
| 06/25/2009 | WO2009079259A2 Antibodies against influenza virus and methods of use thereof |
| 06/25/2009 | WO2009079242A2 Aglycosylated immunoglobulin mutants |
| 06/25/2009 | WO2009078876A1 Assay method for group transfer reactions |
| 06/25/2009 | WO2009078799A1 New vaccine for the treatment of mycobacterium related disorders |
| 06/25/2009 | WO2009078783A1 Breast cancer treatment and treatment prediction |
| 06/25/2009 | WO2009078151A1 Method for measurement of high-molecular-weight adiponectin |
| 06/25/2009 | WO2009077993A2 Treatment of interstitial cystitis |
| 06/25/2009 | WO2009077744A2 Vaccines for brucellosis |
| 06/25/2009 | WO2009077731A2 Prolactin fusion proteins |
| 06/25/2009 | WO2009077569A1 Biokinetics of fast-clearing polypeptides |
| 06/25/2009 | WO2009077531A1 Altering high density lipoprotein levels through udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetlgalactosaminyltransferase (galnt) modulation |
| 06/25/2009 | WO2009077483A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | WO2009077479A2 Altering high-density lipoprotein levels through carboxylesterase 1 modulation |
| 06/25/2009 | WO2009054873A9 Anti-rantes antibodies and methods of use thereof |
| 06/25/2009 | WO2009052400A8 Antibodies that bind to mammalian ngal and uses thereof |
| 06/25/2009 | WO2009048839A3 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 06/25/2009 | WO2009046123A3 Nlrr-1 antagonists and uses thereof |
| 06/25/2009 | WO2009043051A3 Cd23 binding molecules and methods of use thereof |
| 06/25/2009 | WO2009036228A3 Hepatitis b pre-s2 nucleic acid |
| 06/25/2009 | WO2009007848A3 Bioactive peptides and method of using same |
| 06/25/2009 | WO2008149150A3 Polypeptides, antibody variable domains and antagonists |
| 06/25/2009 | US20090165156 Method for increasing the saltwater tolerance of a fish |
| 06/25/2009 | US20090165154 Genetically engineered ungulates for use as bioreactors for human antibodies; reducing transmission of spongiform encephalopy |
| 06/25/2009 | US20090165151 Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators |
| 06/25/2009 | US20090163699 Fc VARIANTS WITH ALTERED BINDING TO FcRn |
| 06/25/2009 | US20090163698 Method for Preparing Antibody Conjugates |
| 06/25/2009 | US20090163415 NT-proBNP, proBNP AND BNP IMMUNOASSAYS, ANTIBODIES AND STABLE STANDARD |
| 06/25/2009 | US20090162943 Reagents and Methods for the Detection of Transmissible Spongiform Encephalopathy |
| 06/25/2009 | US20090162933 Epha2 and hyperproliferative cell disorders |
| 06/25/2009 | US20090162932 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
| 06/25/2009 | US20090162931 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 06/25/2009 | US20090162906 Biocatalysts; mutant and/or chemically modified enzymes; stereoselectively hydrolyze an amino nitrile or cyanohydrin intermediate to produce the corresponding carboxylic acid; e.g. phenylglycinonitrile from benzaldehyde, potassium cyanide and ammonium chloride |
| 06/25/2009 | US20090162878 Methods and compositions for detecting and quantifying sappb |
| 06/25/2009 | US20090162873 Gene encoding a multidrug-resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 06/25/2009 | US20090162871 Using solid support comprising immobilized factor VII activating protease (FSAP) to detect autoantibodies against protease; fibrinolysis a nd blood clotting factors |
| 06/25/2009 | US20090162869 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell |
| 06/25/2009 | US20090162861 Method for suppressing a fret signal, fret signal suppressor agents and use in a method for multiplexing biological events |
| 06/25/2009 | US20090162852 Baalc expression as a diagnostic marker for acute leukemia |
| 06/25/2009 | US20090162847 Rapid detection of the "high-virulent" st-17 clone of group b streptococcus |
| 06/25/2009 | US20090162845 Affinity tag nucleic acid and protein compositions, and processes for using same |
| 06/25/2009 | US20090162844 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase |
| 06/25/2009 | US20090162835 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| 06/25/2009 | US20090162834 Molecular sequence of swine retrovirus and methods of use |
| 06/25/2009 | US20090162831 human parvovirus |
| 06/25/2009 | US20090162422 Single-domain brain-targeting antibody fragments derived from LLAMA antibodies |
| 06/25/2009 | US20090162392 Mutant forms of streptolysin o |
| 06/25/2009 | US20090162391 Vaccine antigens from piscirickettsia salmonis |
| 06/25/2009 | US20090162382 Optimized ca9 antibodies and methods of using the same |
| 06/25/2009 | US20090162381 Method for Treating Vascular Disorders |
| 06/25/2009 | US20090162379 Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor |
| 06/25/2009 | US20090162378 Anti-human cytomegalovius antibodies |
| 06/25/2009 | US20090162375 Resistin antagonists and their use |
| 06/25/2009 | US20090162374 Specific removal of activated immune cells |
| 06/25/2009 | US20090162373 Materials and methods for treatment of hepatitis c |
| 06/25/2009 | US20090162372 Fibronectin ed-b antibodies, conjugates thereof, and methods of use |
| 06/25/2009 | US20090162371 Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 06/25/2009 | US20090162369 Synthetic chimeric peptides |
| 06/25/2009 | US20090162368 Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162366 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 06/25/2009 | US20090162364 Apo-2 ligand |
| 06/25/2009 | US20090162363 Pedf-r receptor and uses |
| 06/25/2009 | US20090162360 Bivalent, bispecific antibodies |
| 06/25/2009 | US20090162359 Bivalent, bispecific antibodies |
| 06/25/2009 | US20090162358 Antigen binding proteins |
| 06/25/2009 | US20090162357 Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 06/25/2009 | US20090162356 CRIg antagonists |
| 06/25/2009 | US20090162355 Treatment of tumors using specific anti-l1 antibody |
| 06/25/2009 | US20090162354 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 06/25/2009 | US20090162350 Novel composition and methods for the treatment of immune related disease |
| 06/25/2009 | US20090162347 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/25/2009 | US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease |
| 06/25/2009 | US20090162290 Method for the synthesis of penta-pendant enantiomer-pure chelators and process for therapeutically active bioconjugates preparation by a covalent binding thereof |
| 06/25/2009 | US20090162285 Anti-inflammatory fusion protein |
| 06/25/2009 | US20090162284 Anti-igf-i receptor antibody |
| 06/25/2009 | US20090162278 Method for Production of Radioisotope Preparations and Their Use in Life Science, Research, Medical Application and Industry |
| 06/25/2009 | DE102007062962A1 Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg) New surface protein mutant of hepatitis B virus HBV surface antigen (HBsAg) |
| 06/25/2009 | CA2709135A1 Treatment of interstitial cystitis |
| 06/25/2009 | CA2708854A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | CA2708836A1 Methods for purifying or depleting molecules or cells of interest |
| 06/25/2009 | CA2708654A1 Breast cancer treatment and treatment prediction |
| 06/25/2009 | CA2708221A1 Antibodies against influenza virus and methods of use thereof |
| 06/25/2009 | CA2707773A1 Binding molecules to the human ox40 receptor |
| 06/25/2009 | CA2707309A1 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |